Ge J - Search Results

1

Dual-target inhibitors based on PARP1: new trend in the development of anticancer research.

Ge J, Yin Y, Li Y, Deng Y, Fu H. Ge J, et al. Future Med Chem. 2022 Apr;14(7):511-525. doi: 10.4155/fmc-2021-0292. Epub 2022 Mar 8. Future Med Chem. 2022. PMID: 35257598 Review.

2

Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice.

Xi M, Ge J, Wang X, Sun C, Liu T, Fang L, Xiao Q, Yin D. Xi M, et al. Among authors: ge j. Bioorg Med Chem. 2016 Jul 15;24(14):3218-30. doi: 10.1016/j.bmc.2016.05.047. Epub 2016 May 24. Bioorg Med Chem. 2016. PMID: 27255176

3

Discovery of small molecule β-catenin suppressors that enhance immunotherapy.

Feng X, Ge J, Fu H, Miao L, Zhao F, Wang J, Sun Y, Li Y, Li Y. Feng X, et al. Among authors: ge j. Bioorg Chem. 2023 Oct;139:106754. doi: 10.1016/j.bioorg.2023.106754. Epub 2023 Jul 28. Bioorg Chem. 2023. PMID: 37536216

4

Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity.

Li Y, Chu X, Yin Y, Li H, Fu H, Feng X, Deng Y, Ge J. Li Y, et al. Among authors: ge j. Front Pharmacol. 2023 Nov 30;14:1289003. doi: 10.3389/fphar.2023.1289003. eCollection 2023. Front Pharmacol. 2023. PMID: 38099141 Free PMC article.

5

The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway.

Li H, Li J, Zhang Y, Zhao C, Ge J, Sun Y, Fu H, Li Y. Li H, et al. Among authors: ge j. Front Pharmacol. 2024 May 9;15:1401979. doi: 10.3389/fphar.2024.1401979. eCollection 2024. Front Pharmacol. 2024. PMID: 38783943 Free PMC article. Review.

6

Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents.

Li Y, Kong X, Chu X, Fu H, Feng X, Zhao C, Deng Y, Ge J. Li Y, et al. Among authors: ge j. Molecules. 2024 Jun 14;29(12):2836. doi: 10.3390/molecules29122836. Molecules. 2024. PMID: 38930900 Free PMC article.

7

Identification of α-tubulin alpha-1B chain as a target of asiatic acid using chemical proteomics in HepG2 hepatoma cells.

Yang H, Yang B, Teng Y, Ge J, Feng X, Tian Y. Yang H, et al. Among authors: ge j. Org Biomol Chem. 2024 Dec 11;22(48):9371-9378. doi: 10.1039/d4ob01298d. Org Biomol Chem. 2024. PMID: 39479883

8

Loureirin B Ameliorates Glycolipid Metabolism Disorders in Ob/ob Mice by Regulating Bile Acid Levels and Modulating Gut Microbiota Composition.

Zhang J, Zhang X, Li G, Ge J, Feng X. Zhang J, et al. Among authors: ge j. Chem Biodivers. 2024 Oct 21:e202401793. doi: 10.1002/cbdv.202401793. Online ahead of print. Chem Biodivers. 2024. PMID: 39431713

9

N'-[(3-[benzyloxy]benzylidene]-3,4,5-trihydroxybenzohydrazide (1) protects mice against colitis induced by dextran sulfate sodium through inhibiting NFκB/IL-6/STAT3 pathway.

Xi M, Wang X, Ge J, Yin D. Xi M, et al. Among authors: ge j. Biochem Biophys Res Commun. 2016 Aug 19;477(2):290-6. doi: 10.1016/j.bbrc.2016.06.059. Epub 2016 Jun 13. Biochem Biophys Res Commun. 2016. PMID: 27311853

10

High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa.

Dimitrion PM, Krevh R, Veenstra J, Ge J, Siddiqui A, Ferguson D, Hans A, Zuniga B, Sidhu K, Daveluy S, Hamzavi I, Zhou L, Adrianto I, Mi QS. Dimitrion PM, et al. Among authors: ge j. Br J Dermatol. 2025 Jan 8:ljaf012. doi: 10.1093/bjd/ljaf012. Online ahead of print. Br J Dermatol. 2025. PMID: 39778115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,547 results

Search Page

Filters